Susquehanna International Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.46M | Sell |
147,158
-75,771
| -34% | -$678K | ﹤0.01% | 6953 |
|
|
2025
Q4 | $1.89M | Buy |
222,929
+86,040
| +63% | +$614K | ﹤0.01% | 5787 |
|
|
2025
Q3 | $715K | Sell |
136,889
-169,180
| -55% | -$645K | ﹤0.01% | 8144 |
|
|
2025
Q2 | $1.06M | Buy |
306,069
+49,286
| +19% | +$147K | ﹤0.01% | 7267 |
|
|
2025
Q1 | $673K | Buy |
256,783
+180,465
| +236% | +$707K | ﹤0.01% | 8244 |
|
|
2024
Q4 | $314K | Buy |
76,318
+33,930
| +80% | +$185K | ﹤0.01% | 9742 |
|
|
2024
Q3 | $300K | Sell |
42,388
-12,003
| -22% | -$89.7K | ﹤0.01% | 9605 |
|
|
2024
Q2 | $355K | Sell |
54,391
-9,329
| -15% | -$63.7K | ﹤0.01% | 9093 |
|
|
2024
Q1 | $529K | Buy |
63,720
+26,082
| +69% | +$254K | ﹤0.01% | 8370 |
|
|
2023
Q4 | $414K | Sell |
37,638
-177,137
| -82% | -$1.49M | ﹤0.01% | 9107 |
|
|
2023
Q3 | $1.81M | Buy |
214,775
+155,358
| +261% | +$1.67M | ﹤0.01% | 5327 |
|
|
2023
Q2 | $746K | Sell |
59,417
-195,480
| -77% | -$2.43M | ﹤0.01% | 7367 |
|
|
2023
Q1 | $4.2M | Buy |
254,897
+218,782
| +606% | +$3.92M | 0.01% | 3711 |
|
|
2022
Q4 | $540K | Sell |
36,115
-69,038
| -66% | -$1.32M | ﹤0.01% | 7654 |
|
|
2022
Q3 | $2.35M | Buy |
105,153
+19,916
| +23% | +$437K | ﹤0.01% | 4604 |
|
|
2022
Q2 | $1.43M | Buy |
85,237
+10,357
| +14% | +$222K | ﹤0.01% | 5669 |
|
|
2022
Q1 | $2.24M | Sell |
74,880
-19,514
| -21% | -$473K | ﹤0.01% | 5219 |
|
|
2021
Q4 | $2.9M | Buy |
94,394
+39,328
| +71% | +$1.24M | ﹤0.01% | 4709 |
|
|
2021
Q3 | $1.74M | Buy |
55,066
+20,033
| +57% | +$674K | ﹤0.01% | 6157 |
|
|
2021
Q2 | $1.28M | Sell |
35,033
-47,966
| -58% | -$1.58M | ﹤0.01% | 7065 |
|
|
2021
Q1 | $2.87M | Buy |
82,999
+71,228
| +605% | +$3.09M | ﹤0.01% | 5068 |
|
|
2020
Q4 | $489K | Buy |
+11,771
| New | +$532K | ﹤0.01% | 8343 |
|
Other funds holding RLAY
SIAU
CC
CC
PA
BG
VCM
NI
TCM